NCT05272319

Brief Summary

This study involves the one-time collection of whole blood or saliva samples for the extraction and storage of DNA for use in ongoing and future ChiLDReN studies.

Trial Health

90
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
171

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Apr 2022

Longer than P75 for all trials

Geographic Reach
2 countries

13 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 13, 2021

Completed
3 months until next milestone

First Posted

Study publicly available on registry

March 9, 2022

Completed
28 days until next milestone

Study Start

First participant enrolled

April 6, 2022

Completed
4.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 27, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 27, 2026

Completed
Last Updated

July 14, 2026

Status Verified

June 1, 2026

Enrollment Period

4.1 years

First QC Date

December 13, 2021

Last Update Submit

July 13, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Augment a repository of DNA

    The major objective of this protocol is to augment a repository of DNA from participants previously enrolled into clinical research but for whom a DNA biosample was not previously collected. The acquisition and storage of DNA from participants will make available an important resource for future and ongoing studies that may evaluate etiology, pathogenesis, biomarkers, pharmacogenomics, and genetic modifiers of these rare disorders.

    beginning of study through study completion, an average of 1 year.

Eligibility Criteria

Age24 Hours - 25 Years
Sexall
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodProbability Sample
Study Population

The eligible study population are those child participants who signed consent to participate in a prior research study that collects DNA biospecimens and for whom the specimen was never obtained. If those participants are still followed by the site.

You may qualify if:

  • For Child Participants
  • Previous enrollment in PROBE or BASIC
  • Exited from one of the aforementioned studies.
  • Consent for DNA sample collection obtained during enrollment during enrollment to one of the aforementioned studies but sample not previously collected.
  • Still followed at the clinical site.

You may not qualify if:

  • <!-- -->
  • Participant is deceased
  • Participant exited from prior study due to violating eligibility criteria
  • Participant cannot be contacted

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (13)

Children's Hospital of Los Angeles

Los Angeles, California, 90027, United States

Location

UCSF Benioff Children's Hospital

San Francisco, California, 94143, United States

Location

Children's Hospital Colorado

Aurora, Colorado, 80045, United States

Location

Children's Healthcare of Atlanta

Atlanta, Georgia, 30322, United States

Location

Lurie Children's Hospital

Chicago, Illinois, 60611, United States

Location

Riley Hospital for Children

Indianapolis, Indiana, 46202, United States

Location

Cincinnati Children's Hospital

Cincinnati, Ohio, 45229, United States

Location

The Children's Hospital of Philadelphia

Philadelphia, Pennsylvania, 19104, United States

Location

UPMC Children's Hospital of Pittsburgh

Pittsburgh, Pennsylvania, 15224, United States

Location

Texas Children's Hospital; Baylor College of Medicine

Houston, Texas, 77030, United States

Location

University of Utah

Salt Lake City, Utah, 84113, United States

Location

Seattle Children's Hospital

Seattle, Washington, 98105, United States

Location

The Hospital for Sick Children

Toronto, Ontario, M5G 1XG, Canada

Location

Biospecimen

Retention: SAMPLES WITH DNA

Participants will have one-time collection of whole blood or saliva for DNA

MeSH Terms

Conditions

Liver Diseases

Condition Hierarchy (Ancestors)

Digestive System Diseases

Study Officials

  • Ed Doo, MD

    National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

    STUDY DIRECTOR
  • Katrina Loh, MD

    National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

    STUDY DIRECTOR
  • John Magee, MD

    University of Michigan

    PRINCIPAL INVESTIGATOR
  • Lisa Henn, PhD

    Arbor Research Collaborative for Health

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
OTHER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 13, 2021

First Posted

March 9, 2022

Study Start

April 6, 2022

Primary Completion

May 27, 2026

Study Completion

May 27, 2026

Last Updated

July 14, 2026

Record last verified: 2026-06

Locations